课题基金 / 基金详情

CALCIUM OVERLOAD AND APOPTOSIS IN VASCULAR TOXICITY

CALCIUM OVERLOAD AND APOPTOSIS IN VASCULAR TOXICITY
血管毒性中的钙超载和细胞凋亡
批准号:
2520437
负责人:
Daniel Joseph Conklin
金额:
$1.17万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
未结题
起止时间:
1998-08-01 至

项目摘要

项目成果

Daniel Joseph Conklin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Toxicant-induced cardiovascular disease is an important and useful model for studying pathological and toxicological mechanisms. The goal of this proposal is to define toxicological mechanisms of action for the cardiovascular-specific toxicant allylamine, using well developed and previously described in vivo toxicant-induced models of vascular pathology. The synthetic primary amine allylamine rat model is used to study toxicological mechanisms involved in myocardial necrosis, atherosclerosis and vascular smooth muscle cell death. The role of calcium overload in allylamine-induced myocardial necrosis and atherosclerotic-like lesions will be assessed by administration of stereoisomers of the calcium channel blocker verapamil, and quantification of cardiovascular lesions, aortic physiology and aortic myosin heavy chain isoforms. The aortic medial vascular smooth muscle toxicity resulting from biochemical manipulation of allylamine intoxication (i.e., combination with beta-aminopropionitrile, phenelzine or hydralazine) will be characterized as either apoptosis or cellular necrosis. Apoptosis will be quantified via aortic in situ terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining and aortic DNA fragmentation by gel electrophoresis and enzyme- linked immunoassay (ELISA). These studies will aid in understanding the mechanisms of xenobiotic amine toxicity and the pathogenesis of cardiovascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cardiovascular Benefits of Inhaled Biogenic Volatile Organic Compounds
  • 批准号:
    10459548
  • 项目类别:
  • 资助金额:
    $19.56万
  • 财政年份:
    2021
  • 负责人:
    Daniel Joseph Conklin
  • 依托单位:
Cardiovascular Benefits of Inhaled Biogenic Volatile Organic Compounds
  • 批准号:
    10288039
  • 项目类别:
  • 资助金额:
    $23.41万
  • 财政年份:
    2021
  • 负责人:
    Daniel Joseph Conklin
  • 依托单位:
Animal Models and Phenotyping Core
  • 批准号:
    10208902
  • 项目类别:
  • 资助金额:
    $19.76万
  • 财政年份:
    2018
  • 负责人:
    Daniel Joseph Conklin
  • 依托单位:
Animal Models and Phenotyping Core
  • 批准号:
    10452736
  • 项目类别:
  • 资助金额:
    $19.76万
  • 财政年份:
    2018
  • 负责人:
    Daniel Joseph Conklin
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: